中生北控生物科技中期报告2025

GEM GEMGEMGEM GEMGEMGEM GEMGEM(1)(2) 5 6 7 17 18 21 22 27 1866 http://www.zhongsheng.com.cn H 1617 CPA, CPA (U.S.) H GEM8247H64,286,143HH1.00 CPA, CFA 30600 HGEM ^ IVDIVD IVD IVDIVD 9,5801.33828.4% 3,7405,85036.1%39.0%43.7% 2,0303,16035.7% 2,3302,2304.4% 1,3301,69021.0%762019-nCoV1 2,2901,83025.1% IVD6.3%3.7%2023IVD1,20017050%IVD6,50090018.5%1,33218711%1,9002672,700 IVDIVDIVD SinoCyte421BioCyteX202522201504 10%15% IVD IVD+ 7,950 1,9802104,0004,1801,7801,000 30240 800 4715544,2705,210 1. 26,772,000 2. 21 3. 89% 10% 4. 5. 1,082,0001,562,000(a)967,0001,197,000(b)46,000296,000(c)49,00049,000(d)20,00020,000 6. 25% 15% 6. 7. 144,707,176144,707,176 8. 9. 346712122 10. 346712122 3090 11. 12. 80,421,03380,421,033164,286,14364,286,143H1 13. 2,000,0002,000,000 14. (a) 14. 14. (i)20504,500,0004,500,000 (ii)2008% 15. 571XV352GEM5.465.68 352GEM5.465.68 XV23336 1.36.01%36.01%H 2.43.12%H 3.99.5% 4.77.94% 5. XV23336 GEM GEM GEM5.485.67GEM GEM GEMC1 D.2.5 D.2.5(i)GEM(ii) GEM17.50A(1) GEM17.50A(1) (1)(i)(ii)3.05(iii) (2)(i)(ii) GEM17.50A(1)